Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer

被引:0
|
作者
Rui Kang
Yangchun Xie
Qiuhong Zhang
Wen Hou
Qingping Jiang
Shan Zhu
Jinbao Liu
Dexing Zeng
Haichao Wang
David L Bartlett
Timothy R Billiar
Herbert J Zeh
Michael T Lotze
Daolin Tang
机构
[1] The Third Affiliated Hospital,Department of Medicine
[2] Center for DAMP Biology,Department of Surgery
[3] Key Laboratory for Major Obstetric Diseases of Guangdong Province,undefined
[4] Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes,undefined
[5] Protein Modification and Degradation Laboratory,undefined
[6] Guangzhou Medical University,undefined
[7] University of Pittsburgh,undefined
[8] Laboratory of Emergency Medicine,undefined
[9] The Feinstein Institute for Medical Research,undefined
[10] Hillman Cancer Center,undefined
[11] University of Pittsburgh,undefined
来源
Cell Research | 2017年 / 27卷
关键词
HMGB1; RAGE; histone; K-Ras; pancreatic cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Pancreatic ductal adenocarcinoma (PDAC) driven by oncogenic K-Ras remains among the most lethal human cancers despite recent advances in modern medicine. The pathogenesis of PDAC is partly attributable to intrinsic chromosome instability and extrinsic inflammation activation. However, the molecular link between these two events in pancreatic tumorigenesis has not yet been fully established. Here, we show that intracellular high mobility group box 1 (HMGB1) remarkably suppresses oncogenic K-Ras-driven pancreatic tumorigenesis by inhibiting chromosome instability-mediated pro-inflammatory nucleosome release. Conditional genetic ablation of either single or both alleles of HMGB1 in the pancreas renders mice extremely sensitive to oncogenic K-Ras-driven initiation of precursor lesions at birth, including pancreatic intraepithelial neoplasms, intraductal papillary mucinous neoplasms, and mucinous cystic neoplasms. Loss of HMGB1 in the pancreas is associated with oxidative DNA damage and chromosomal instability characterized by chromosome rearrangements and telomere abnormalities. These lead to inflammatory nucleosome release and propagate K-Ras-driven pancreatic tumorigenesis. Extracellular nucleosomes promote interleukin 6 (IL-6) secretion by infiltrating macrophages/neutrophils and enhance oncogenic K-Ras signaling activation in pancreatic lesions. Neutralizing antibodies to IL-6 or histone H3 or knockout of the receptor for advanced glycation end products all limit K-Ras signaling activation, prevent cancer development and metastasis/invasion, and prolong animal survival in Pdx1-Cre;K-RasG12D/+;Hmgb1−/− mice. Pharmacological inhibition of HMGB1 loss by glycyrrhizin limits oncogenic K-Ras-driven tumorigenesis in mice under inflammatory conditions. Diminished nuclear and total cellular expression of HMGB1 in PDAC patients correlates with poor overall survival, supporting intracellular HMGB1 as a novel tumor suppressor with prognostic and therapeutic relevance in PDAC.
引用
收藏
页码:916 / 932
页数:16
相关论文
共 50 条
  • [31] HMGB1 as the therapeutic target in gastric cancer
    Takaki, Wataru
    Konishi, Hirotaka
    Arita, Tomohiro
    Kosuga, Toshiyuki
    Shiozaki, Atsushi
    Nakanishi, Masayoshi
    Kubota, Takeshi
    Fujiwara, Hitoshi
    Okamoto, Kazuma
    Otsuji, Eigo
    CANCER SCIENCE, 2021, 112 : 429 - 429
  • [32] Role of Serum HMGB1 in Prostate Cancer
    Solakhan, Mehmet
    Cicek, Hulya
    Benlier, Necla
    Yildirim, Zeliha
    Sever, Ozlem Nuray
    Orhan, Nun
    Yildirim, Mustafa
    EUROPEAN JOURNAL OF THERAPEUTICS, 2020, 26 (02): : 108 - 112
  • [33] The Role of HMGB1 in Radioresistance of Bladder Cancer
    Shrivastava, Sanhita
    Mansure, Jose Joao
    Almajed, Wael
    Cury, Fabio
    Ferbeyre, Gerardo
    Popovic, Marija
    Seuntjens, Jan
    Kassouf, Wassim
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (03) : 471 - 479
  • [34] HMGB1 in Cancer: Good, Bad, or Both?
    Kang, Rui
    Zhang, Qiuhong
    Zeh, Herbert J., III
    Lotze, Michael T.
    Tang, Daolin
    CLINICAL CANCER RESEARCH, 2013, 19 (15) : 4046 - 4057
  • [35] Variation of HMGB1 expression in breast cancer
    Flohr, AM
    Rogalla, P
    Meiboom, M
    Borrmann, L
    Krohn, M
    Thode-Halle, B
    Bullerdiek, J
    ANTICANCER RESEARCH, 2001, 21 (6A) : 3881 - 3885
  • [36] Encapsulation of pancreatic islet with HMGB1 fragment for attenuating inflammation
    Jo E.H.
    Hwang Y.H.
    Lee D.Y.
    Biomaterials Research, 19 (1)
  • [37] miR-345 is a novel tumor suppressor microRNA in pancreatic cancer
    Srivastava, Sanjeev K.
    Singh, Seema
    Bhardwaj, Arun
    Grizzle, William E.
    Singh, Ajay P.
    CANCER RESEARCH, 2011, 71
  • [38] HMGB1 PROMOTES TUMOR PROGRESSION AND INVASION THROUGH HMGB1/TNFR1/NF-κB AXIS IN CASTRATION-RESISTANT PROSTATE CANCER
    Jung, Ae Ryang
    Park, Yong Hyun
    Shin, Dong Ho
    Moon, Hyong Woo
    Ha, U-Syn
    Hong, Sung-Hoo
    Lee, Ji Youl
    Kim, Sae Woong
    JOURNAL OF UROLOGY, 2021, 206 : E607 - E607
  • [39] Is 15-lipoxygenase-1 a tumor suppressor in pancreatic cancer?
    Noor, S.
    Hennig, R.
    Rao, S. M.
    Buchler, M. W.
    Fuerstenberger, G.
    Fries, H.
    Adrian, T. E.
    Krieg, P.
    PANCREAS, 2006, 33 (04) : 486 - 486
  • [40] PPM1G promotes autophagy and progression of pancreatic cancer via upregulating HMGB1
    Song, Mingyang
    Xu, Min
    Zhang, Qi
    Fan, Tingyu
    Xu, Jiajia
    Hang, Cheng
    Cheng, Cuie
    Ou, Xilong
    Gong, Chen
    Lu, Qin
    CELLULAR SIGNALLING, 2024, 123